N/A
Manufactured by Rising Pharma Holdings, Inc.
4,811 FDA adverse event reports analyzed
Last updated: 2026-04-15
MECLIZINE HCL is a medication tracked in the FDA Adverse Event Reporting System (FAERS), manufactured by Rising Pharma Holdings, Inc.. The most commonly reported adverse reactions for MECLIZINE HCL include FATIGUE, DIZZINESS, DRUG INEFFECTIVE, FALL, NAUSEA. This page provides a comprehensive breakdown of reported side effects, safety signals, patient demographics, and AI-powered safety analysis for MECLIZINE HCL.
Out of 2,181 classified reports for MECLIZINE HCL:
The FDA classifies an adverse event as “serious” if it results in death, hospitalization, disability, congenital anomaly, or requires intervention to prevent permanent damage.
Demographics reflect voluntary FDA adverse event reporting patterns and may not represent the full patient population.